K212522 is an FDA 510(k) clearance for the Lilliput APD System, a System, Peritoneal, Automatic Delivery (Class II — Special Controls, product code FKX), submitted by Fresenius Medical Care Renal Therapies Group, LLC (Waltham, US). The FDA issued a Cleared decision on April 15, 2022, 247 days after receiving the submission on August 11, 2021. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5630.
| 510(k) Number | K212522 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 11, 2021 |
| Decision Date | April 15, 2022 |
| Days to Decision | 247 days |
| Submission Type | Traditional |
| Review Panel | Gastroenterology & Urology (GU) |
| Summary | Summary PDF |
| Product Code | FKX — System, Peritoneal, Automatic Delivery |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 876.5630 |